Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
BMC Cancer|July 10, 2025
Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world studyQi-Yu Chi, Quan-Yuan Liu, Shuang-Jia Wang, et al.
International Journal of Surgery (London, England)|March 28, 2023
Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic areaXin-Fei Xu, Yong-Kang Diao, Yong-Yi Zeng, et al.
Hepatology International|October 25, 2023
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinomaShi-Chuan Tang, Kai-Ling Zhang, Kong-Ying Lin, et al.
Oncotarget|September 24, 2016
Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinomaJie Cai, Sheng-Xian Yuan, Fu Yang, et al.
Frontiers in Oncology|March 27, 2023
Perioperative and long-term survival outcomes of laparoscopic versus open hepatectomy for BCLC stage A large hepatocellular carcinoma patients in difficult segments: A two-centre, propensity score matching analysisDong-Yang Ding, Lei Liu, Kong-Ying Lin, et al.
Frontiers in Oncology|June 21, 2024
Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (γ)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational studyShi-Chuan Tang, Ye-Ye Wu, Zhi-Wen Lin, et al.
Molecular Cancer|September 18, 2015
Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaQi-Fei Tao, Sheng-Xian Yuan, Fu Yang, et al.
Annals of Surgical Oncology|December 1, 2023
Impact of Hepatic Pedicle Clamping on Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma: Stratified Analysis Based on Intraoperative Blood Transfusion StatusShi-Chuan Tang, Jia-Hao Xu, Yi-Fan Yang, et al.
Hepatology International|June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patientsKong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Frontiers in Immunology|March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective studyKong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
Pageof 4